Effect of growth hormone replacement therapy on the quality of life in women with growth hormone deficiency who have a history of acromegaly versus other disorders

Endocrine Practice

Volumn 18, Issue 2, 2012, Pages 209-218

  Valassi, Elena ^a   Brick, Danielle J ^a   Johnson, Jessica C ^a   Biller, Beverly M K ^a   Klibanski, Anne ^a   Miller, Karen K ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ESTROGEN; GROWTH HORMONE; SOMATOMEDIN C;

ACROMEGALY; ADULT; ALCOHOL CONSUMPTION; ARTICLE; BODY MASS; CLINICAL ARTICLE; DIABETES INSIPIDUS; FEMALE; GROWTH HORMONE BLOOD LEVEL; GROWTH HORMONE DEFICIENCY; GROWTH HORMONE RELEASE; HORMONE SUBSTITUTION; HUMAN; HYPOGONADISM; HYPOPHYSIS DISEASE; HYPOTHALAMUS DISEASE; HYPOTHYROIDISM; INSULIN TOLERANCE TEST; MALE; MEDICAL HISTORY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SHORT FORM 36; SMOKING;

EID: 84859841972     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11134.OR     Document Type: Article

References (29)

1. Biermasz NR, van Thiel SW, Pereira AM, et al. Decreased quality of life in patients with acromegaly despite long-term cure of growth hormone excess. J Clin Endocrinol Metab. 2004;89:5369-5376.
2. van der Klaauw AA, Kars M, Biermasz NR, et al. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf). 2008;69:775-784.
3. Wexler T, Gunnell L, Omer Z, et al. Growth hormone deficiency is associated with decreased quality of life in patients with prior acromegaly. J Clin Endocrinol Metab. 2009;94:2471-2477.
4. Miller KK, Wexler T, Fazeli P, et al. Growth hormone deficiency after treatment of acromegaly: A randomized, placebo-controlled study of growth hormone replacement. J Clin Endocrinol Metab. 2010;95:567-577.
5. Attanasio AF, Lamberts SW, Matranga AM, et al (Adult Growth Hormone Deficiency Study Group). Adult growth hormone (GH)-deficient patients demonstrate heterogeneity between childhood onset and adult onset before and during human GH treatment. J Clin Endocrinol Metab. 1997;82:82-88.
6. Burman P, Broman JE, Hetta J, et al. Quality of life in adults with growth hormone (GH) deficiency: Response to treatment with recombinant human GH in a placebo-controlled 21-month trial. J Clin Endocrinol Metab. 1995;80: 3585-3590.
7. Cuneo RC, Judd S, Wallace JD, et al. The Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults. J Clin Endocrinol Metab. 1998;83: 107-116.
8. McGauley GA, Cuneo RC, Salomon F, Sönksen PH. Psychological well-being before and after growth hormone treatment in adults with growth hormone deficiency. Horm Res. 1990;33(suppl 4):52-54.
9. Koltowska-Häggström M, Mattsson AF, Shalet SM. Assessment of quality of life in adult patients with GH deficiency: KIMS contribution to clinical practice and pharmacoeconomic evaluations. Eur J Endocrinol. 2009;161(suppl 1):S51-S64.
10. Kellner R. A symptom questionnaire. J Clin Psychiatry. 1987;48:268-274.
11. McHorney CA, Ware JE Jr, Raczek AE. The MOS 36-Item Short-Form Health Survey (SF-36): II. Psychometric and clinical tests of validity in measuring physical and mental health constructs. Med Care. 1993;31:247-263.
12. McKenna SP, Doward LC, Alonso J, et al. The QoL-AGHDA: An instrument for the assessment of quality of life in adults with growth hormone deficiency. Qual Life Res. 1999;8:373-383.
13. Ware JE, Snow KK, Kosinski M, Gandek B. SF-36 Health Survey Manual and Interpretation Guide. Boston, MA: New England Medical Center, The Health Institute, 1993.
14. Beauregard C, Utz AL, Schaub AE, et al. Growth hormone decreases visceral fat and improves cardiovascular risk markers in women with hypopituitarism: A randomized, placebo-controlled study. J Clin Endocrinol Metab. 2008;93:2063-2071.
15. Hartman ML, Crowe BJ, Biller BM, Ho KK, Clemmons DR, Chipman JJ (HypoCCS Advisory Board; U.S. HypoCCS Study Group). Which patients do not require a GH stimulation test for the diagnosis of adult GH deficiency? J Clin Endocrinol Metab. 2002;87:477-485.
16. Biller BM, Samuels MH, Zagar A, et al. Sensitivity and specificity of six tests for the diagnosis of adult GH deficiency. J Clin Endocrinol Metab. 2002;87:2067-2079.
17. Feldt-Rasmussen U, Abs R, Bengtsson BA, et al (KIMS International Study Board of KIMS Study Group). Growth hormone deficiency and replacement in hypopituitary patients previously treated for acromegaly or Cushing's disease. Eur J Endocrinol. 2002;146:67-74.
18. van der Klaauw AA, Bax JJ, Roelfsema F, et al. Limited effects of growth hormone replacement in patients with GH deficiency during long-term cure of acromegaly. Pituitary. 2009;12:339-346.
19. Murray RD, Shalet SM. Adult growth hormone replacement: Lessons learned and future direction. J Clin Endocrinol Metab. 2002;87:4427-4428.
20. Woodhouse LJ, Mukherjee A, Shalet SM, Ezzat S. The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocr Rev. 2006;27:287-317.
21. Biermasz NR, Pereira AM, Smit JW, Romijn JA, Roelfsema F. Morbidity after long-term remission for acromegaly: Persisting joint-related complaints cause reduced quality of life. J Clin Endocrinol Metab. 2005;90: 2731-2739.
22. Agewall S, Berglund M, Henareh L. Reduced quality of life after myocardial infarction in women compared with men. Clin Cardiol. 2004;27:271-274.
23. Mainio A, Tuunanen S, Hakko H, Niemelä A, Koivukangas J, Räsänen P. Decreased quality of life and depression as predictors for shorter survival among patients with low-grade gliomas: A follow-up from 1990 to 2003. Eur Arch Psychiatry Clin Neurosci. 2006;256:516-521.
24. Mortensen OS, Bjorner JB, Newman B, et al (DANAMI-2 Study Group). Gender differences in health-related quality of life following ST-elevation myocardial infarction: Women and men do not benefit from primary percutaneous coronary intervention to the same degree. Eur J Cardiovasc Prev Rehabil. 2007;14:37-43.
25. Kauppinen-Mäkelin R, Sane T, Sintonen H, et al. Quality of life in treated patients with acromegaly. J Clin Endocrinol Metab. 2006;91:3891-3896.
26. Rowles SV, Prieto L, Badia X, Shalet SM, Webb SM, Trainer PJ. Quality of life (QOL) in patients with acromegaly is severely impaired: Use of a novel measure of QOL; acromegaly quality of life questionnaire. J Clin Endocrinol Metab. 2005;90:3337-3341.
27. Florkowski CM, Stevens I, Joyce P, Espiner EA, Donald RA. Growth hormone replacement does not improve psychological well-being in adult hypopituitarism: A randomized crossover trial. Psychoneuroendocrinology. 1998;23: 57-63.
28. Baum HB, Katznelson L, Sherman JC, et al. Effects of physiological growth hormone (GH) therapy on cognition and quality of life in patients with adult-onset GH deficiency. J Clin Endocrinol Metab. 1998;83:3184-3189.
29. Norrman LL, Johannsson G, Sunnerhagen KS, Svensson J. Baseline characteristics and the effects of two years of growth hormone (GH) replacement therapy in adults with GH deficiency previously treated for acromegaly. J Clin Endocrinol Metab. 2008;93:2531-2538.